Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Hdl Handle:
http://hdl.handle.net/10144/619068
Title:
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
Authors:
Deen, J; Lopez, AL; Kanungo, S; Wang, XY; Anh, DD; Tapia, M; Grais, RF
Journal:
Human Vaccines & Immunotherapeutics
Abstract:
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.
Publisher:
Taylor & Francis
Issue Date:
14-Nov-2017
URI:
http://hdl.handle.net/10144/619068
DOI:
10.1080/21645515.2017.1403705
PubMed ID:
29135339
Submitted date:
2018-02-01
Language:
en
ISSN:
2164-554X
Appears in Collections:
Vaccination

Full metadata record

DC FieldValue Language
dc.contributor.authorDeen, Jen
dc.contributor.authorLopez, ALen
dc.contributor.authorKanungo, Sen
dc.contributor.authorWang, XYen
dc.contributor.authorAnh, DDen
dc.contributor.authorTapia, Men
dc.contributor.authorGrais, RFen
dc.date.accessioned2018-02-06T16:30:16Z-
dc.date.available2018-02-06T16:30:16Z-
dc.date.issued2017-11-14-
dc.date.submitted2018-02-01-
dc.identifier.citationImproving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? 2017:1-5 Hum Vaccin Immunotheren
dc.identifier.issn2164-554X-
dc.identifier.pmid29135339-
dc.identifier.doi10.1080/21645515.2017.1403705-
dc.identifier.urihttp://hdl.handle.net/10144/619068-
dc.description.abstractThere are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.en
dc.language.isoenen
dc.publisherTaylor & Francisen
dc.rightsArchived with thanks to Human Vaccines & Immunotherapeuticsen
dc.titleImproving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?en
dc.identifier.journalHuman Vaccines & Immunotherapeuticsen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.